Arrowhead Pharmaceuticals
ARWR
Arrowhead Pharmaceuticals (ARWR) news
Recent news
Stifel raises target price to $104 from $98 for Arrowhead Pharmaceuticals
AInvest Wire · Aug 5, 2026Arrowhead Pharma 3Q loss/share $1.36, est. loss/share $1.35
AInvest Wire · Aug 4, 2026Arrowhead Pharmaceuticals buys FDA priority review voucher
AInvest Wire · Aug 4, 2026Arrowhead Pharmaceuticals - Yosemite Phase 3 study completion anticipated in mid-2027
AInvest Wire · Jul 27, 2026Arrowhead Pharmaceuticals, Inc.: H.C. Wainwright raises target price to $115 from $100
AInvest Wire · Jul 27, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.